Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-05 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.360 | -0.500 | -0.1400 | ||||
REV | 1.690M | 168.000K | -1.522M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
EVFM | Evofem Biosciences | 1.65 | 0.01 | 0.61% | 164.4M |
You can purchase shares of Evofem Biosciences (NASDAQ: EVFM) through any online brokerage.
Other companies in Evofem Biosciences’s space includes: Onconova Therapeutics (NASDAQ:ONTX), Satsuma Pharmaceuticals (NASDAQ:STSA) and SCYNEXIS (NASDAQ:SCYX).
The latest price target for Evofem Biosciences (NASDAQ: EVFM) was reported by HC Wainwright & Co. on 2021-03-08. The analyst firm set a price target for 7.00 expecting EVFM to rise to within 12 months (a possible 326.83% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Evofem Biosciences (NASDAQ: EVFM) is $1.64 last updated Today at 8:00:02 PM.
There are no upcoming dividends for Evofem Biosciences.
There is no upcoming split for Evofem Biosciences.